Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetals Exploration Regulatory News (MTL)

Share Price Information for Metals Exploration (MTL)

Share Price is delayed by 15 minutes
Get Live Data
13.15    0.00 (0.00%)
Bid:
13.00
Ask:
13.30
Spread: 0.30 (2.308%)
Market Cap: £393.37m
MTL Live PriceLast checked at - London Stock Exchange

Intraday Metals Exploration Share Chart

Runruno Scoping Study Update

15 Jul 2008 07:00

RNS Number : 0459Z
Metals Exploration PLC
15 July 2008
 



Metals Exploration PLC

Runruno Scoping Study - Update

BIOX® selected as preferred process route

15 July 2008

Metals Exploration PLC ('Metals Ex' or 'the Company'), the natural resources exploration and development Company with assets in the Pacific Rim region, is pleased to provide an update on the progress of the Scoping Study being conducted on its Runruno gold-molybdenum deposit in the Philippines.

Highlights:

BIOX® technology selected as the preferred processing technology following a detailed assessment of the gold and potential molybdenum recovery and the likely capital and operating costs. 

Ausenco well advanced in process design and capital and operating cost estimation.

Diamond and RC drilling completed for this stage.

Design and costing of infrastructure components proceeding well with no fatal flaws identified.

Study expected to be finalised in late August - early September

Processing 

BIOX® processing technology has been selected as the preferred technology to be used in the oxidisation circuit for processing ore at Runruno.

Both BIOX® and Pressure Oxidation (POX) technologies have been shown by test-work to be equally applicable to processing Runruno ores with excellent gold recovery and good dissolution of molybdenum. In order to assess the application of the technologies to Runruno and to provide a basis for selecting a preferred processing route, the Company commissioned Gold Fields Mining Services to undertake a study on the capital (Capex) and operating (Opex) costs and the benefits and disadvantages of the BIOX® technology. Similarly, a study of the POX technology was undertaken by Ausenco.

The results of these comparative studies have shown that the Capex and Opex cost regime estimated for BIOX® technology is significantly lower than that estimated for POX; with BIOX® Capex estimated at about 50% and Opex at about 66% of that estimated for POX. Analysis of the benefits and disadvantages of the two technologies has shown BIOX® to be of a lower operating risk and more suited to the application proposed.

As a direct consequence of the finalisation of the gold processing route, molybdenum recovery test-work will now be focussed on a chemical recovery process rather than a physical process such as recovery into a saleable flotation concentrate. To date, BIOX® test-work has been encouraging with up to 78% of the molybdenum contained in concentrate being dissolved during oxidation. When combined with recoveries into the flotation concentrate, the Company is targeting overall molybdenum recoveries of around 50%, implying annual production of approximately 2 mlbs Mo per annum.

The ongoing test-work program will now focus on the recovery of the molybdenum from solution and the optimisation of the dissolution of the molybdenum. Work has commenced on this program.

Process Design

Ausenco is well advanced with process design and the Capex and Opex estimates for the processing plant. The metallurgical circuit and layout is proving to be relatively straightforward, and now that BIOX® has been chosen as the preferred process route the circuit is likely to share a number of similarities with Sino Gold's Jinfeng mine in China.

It is expected that this component of the study will be completed during August.

Resource Drilling

The drilling program designed to support the Scoping Study is now complete. All of the holes have been sampled and submitted for assay with about half returned to date. The majority of the holes completed were in-fill holes designed to add certainty to the resource estimate. 

Once all the assay data has been received and the geological interpretation and model confirmed the mineral resource will be re-estimated. Subject to receipt of assay data the resource update should be available by the end of August. This updated resource will then be used as a base to finalise mine planning.

Drilling using three diamond drill rigs is continuing on the boundaries of the resource.

Infrastructure

Infrastructure studies are proceeding well with no fatal flaws identified. Parsons Brinkerhoff and GHD along with a number of other Philippine based specialists have been retained by the Company to assist with these works.

Scoping Study

The Scoping Study is proceeding satisfactorily after some delays caused by the unsatisfactory performance of the drilling contractor during the early stages of the program and the widespread shortage of senior experienced technical resources endemic in the industry. Both these issues have been successfully addressed.

It is now expected that the study will be finalised late in August - or early September.

Jonathan Beardsworth, Chief Executive of Metals Ex, said: 

"It is pleasing to be able to report that the Scoping Study is making such good progress across a range of disciplines - in-fill drilling, resource update, mineplanning, selection of process route, likely moly recoveries, and infrastructure studies.

Our confidence in the resource and the likelihood of being able to develop a mine at Runruno grows with every report received"

For more information:

 

Jonathan Beardsworth + 44 (0) 20 7927 6690

CEO + 44 (0) 7747 101 552Tim Feather +44 (0) 20 7601 6100

Hanson Westhouse

Charles Vivian + 44 (0) 20 7743 6672Pelham PR

Klara Kaczmarek + 44 (0) 20 3159 4395Pelham PR

QUALIFIED/COMPETENT PERSONS

Mr Ian Holzberger, who is the Project Director for the development of the Runruno Project and a Director of the Company, has been involved in the mining and exploration industry for more than 35 years. He has compiled, read and approved the technical disclosure in this regulatory announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDRCXBGGIS
Date   Source Headline
9th Oct 20182:08 pmRNSBanking and Operational Update
28th Sep 20187:16 amRNSInterim Results
17th Sep 20188:26 amRNSTyphoon Mangkhut
29th Aug 201810:37 amRNSBanking Update
31st Jul 20188:47 amRNSBanking Update
25th Jul 20187:00 amRNSWorking Capital Funding
23rd Jul 201810:15 amRNSQuarterly Update To 30 June 2018
5th Jul 20189:19 amRNSOperations Update
29th Jun 201811:05 amRNSBanking Update
19th Jun 20183:20 pmRNSResult of AGM
24th May 20187:00 amRNSFinal Results For The Year Ended 31 December 2017
18th May 20187:00 amRNSAnnual General Meeting Announcement
10th May 20181:15 pmRNSDirectorate Change
20th Apr 20187:00 amRNSQuarterly Update To 31 March 2018
16th Apr 20187:25 amRNSDIRECTOR/PDMR SHAREHOLDING
9th Apr 20186:10 pmRNSDIRECTOR/PDMR SHAREHOLDING
29th Mar 20187:00 amRNSStandby Funding
23rd Jan 20187:00 amRNSQuarterly Update To 31 December 2017
28th Dec 20177:00 amRNSRunruno Scheduled Capital & Interest Payment
13th Dec 20177:00 amRNSRunruno Project Update to 12 December
19th Oct 20177:00 amRNSQuarterly Update To 30 September 2017
2nd Oct 20178:33 amRNSUS$21m Mezzanine Facility Documentation Completed
29th Sep 201711:45 amRNSInterim Results
29th Sep 201711:45 amRNSMezzanine Debt Facility
19th Sep 20177:00 amRNSOperations and Mezzanine Debt Facility Update
26th Jul 20177:00 amRNSQuarterly Update To 30 June 2017
30th Jun 20177:00 amRNSShort Term Funding Secured
15th Jun 201712:36 pmRNSResults of AGM
31st May 20177:00 amRNSFunding Update
24th May 20178:40 amRNSFunding
22nd May 20177:00 amRNSFinal Results For The Year Ended 31 December 2016
18th May 20177:00 amRNSAnnual General Meeting Announcement
24th Apr 201710:15 amRNSQuarterly Update To 31 March 2017
10th Apr 20178:28 amRNSDirector Resignation
15th Mar 20177:00 amRNSRunruno Gold project Update
18th Jan 201710:00 amRNSAppointment of Nominated Adviser and Broker
13th Jan 201711:14 amRNSDirector's Share Dealing
12th Jan 20171:50 pmRNSHolding(s) in Company
10th Jan 20179:50 amRNSDirector/PDMR Shareholding
19th Dec 201610:48 amRNSRescheduled Facility Agreement
8th Dec 20168:12 amRNSHolding(s) in Company
29th Nov 20167:33 amRNSFirst Gold Sale, Debt Rescheduling, Ramp Up
14th Nov 20167:00 amRNSEquity Raising
4th Oct 20163:04 pmRNSResults of General Meeting of Shareholders
30th Sep 20169:03 amRNSInterim Results
15th Sep 20161:52 pmRNSHolding(s) in Company
14th Sep 201611:19 amRNSNotice of General Meeting
8th Sep 20169:54 amRNSEquity Raising
26th Aug 201611:38 amRNSRunruno Gold Project Update
25th Jul 20162:37 pmRNSEquity Raising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.